Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Interesting that Classen filed the amicus brief...
Jbog,
I'm sure you've said before, but I really can't recall, so can you go into some more detail on your issues with MNTAs current management (outside of their stock selling plan)?
A ringing endorsement if I've ever heard one! :)
MNTA en banc: Is it reasonable to assume we should be hearing any day now on whether the court will grant?
You should make a list! :)
Moreover, Teva does not exactly have a history of playing straight with its regulatory disclosures to investors; Lovenox is a case in point.
naz lost like 2% yesterday with bios getting hard...That was most likely the reason considering the low volume..
FWIW I added some today
retailers seem obsessed with NCE approval
Baral is correct if AMRN were to get NCE and defend it's patents until 2030. However, I think it is unlikely that both or even one of those scenarios is in the cards. Without NCE AMRN will immediately face a paragraph IV challenge and I imagine would settle for a generic entry somewhere around 2018-2020.
Of course, if they somehow (on another note, does anyone know of other cases of delayed NCE like this?) get NCE, then that changes dramatically.
From reading DDs post, he wasn't banking on it and frequently mentioned it was unlikely the case.
If you were referring to today's drop, the volume was miniscule and wouldn't make anything of it.
Steve,
IR responded to me earlier this week that they don't divulge execs personal finances. Unfortunately, this is no longer the age of Bev (although I'm warming up to Lora) :)
My conclusion is similar that it would be buy-out related, although it is obviously still too early to tell if they have in fact stopped them.
But while we're on the topic, what would be a fair price for MNTA at this juncture. I would hope they wouldn't take anything less than $2b....
MNTA IR did get back to me, and as expected said they do not disclose personal finances of execs :P
Is there any precedent for execs in a company canceling their plans before some sort of news?
ahh interesting. I did not know that. Thank for clearing that up.
In the past few years, I don’t think there’s been a period as long as 23 days without at least one insider sale.
FWIW I actually just asked IR if they suspended them...
Personally, like jbog, I don't make much of it as they have gone this long and longer before without them. If a few more weeks past, then it may be of note.
Generally, I agree with you, but CW has consistently understated things so when he says something with confidence, I tend to take it at relative face value.
I agree. Enjoyed hearing craig' confidence on en banc/m-copax and the whole company going forward....
Probably a stupid question, but if the case goes to en banc, MNTA would need 5 of the 9 to win, yes?
CW seems pretty confident in getting that en banc. Nice to hear
It seems to me they are posturing a bit. I wouldn't be surprised to see a similar 8K next month.
I agree with AF that AMRN is being dishonest here....
a) given the fact that these opinions are circulated prior to release (as you point out), then the dissenter probably has at least a partial feel for the opinions of the court as a whole.
Is there statistics on how many cases the supreme court takes? Would you then say MNTA has a greater chance of overturning it that way?
Is there any chance the 2 in the majority could change their vote upon hearing something new at the en banc?
they're just staffing it up. It's going to be slower, so I'm kind of thinking it will be more in that 18- to 24-month range.
I, for one, really really really appreciate your selfless altruism JM. You're absolutely right. MNTA has not done a single thing this board has said it would and the company shouldn't even be worth the $400m+ cash on hand. Thank you SOOOOOOOOO much for posting here. It is SOOOOOOOOOOOO helpful.
Possible rumours of settlement negotiations with Amphastar?
Any court updates? we were a little green today :P
Okay. So I guess my question is did anything from the webcast lead you to believe that an en banc would actually be granted?
A third outcome is that a given patent is found to be valid, but the P-IV challengers are able to demonstrate non-infringement. Actually, some combination of patent invalidity and non-infringement will likely be needed for the challengers to get around the full suite of AMRN’s AMR101 patents.
why would you say it's "more and more likely" at this point?
If the case can get there, I can't see them being kind to this ruling either considering how erroneous and shortsighted the judgement was.
I'm relatively impressed MNTA is back to 14, for now at least.
IO you are citing posts where you are clearly wrong and your agenda is obvious... not getting why you're calling out Clark....
lol. you edited your post. I don't care what you have to say anyway because you're clearly guided by an agenda. If M-Copax was approved tomorrow we'd never hear from you again.
The Chief Judge in his dissent expressly invited Momenta to request reconsideration en banc:
I can see other companies besides TEVA getting involved as well if the decision holds and MNTAs patents are allowed to be infringed.
"The opinion outlined in the ruling is a setback for Momenta in this particular litigation and has potentially wide ranging implications for all patent holders," commented Craig Wheeler, President and Chief Executive Officer of Momenta. "We are reviewing the court's opinion and are considering our options for moving forward in this ongoing case."